Ghisallo Capital Management LLC Intellia Therapeutics, Inc. Transaction History

Ghisallo Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$33.3 - $44.82 $4.16 Million - $5.6 Million	-125,000 Reduced 50.0%	125,000 $4.66 Million
Q4 2022 Feb 14, 2023	BUY	$33.21 - $62.69 $8.3 Million - $15.7 Million	250,000 New	250,000 $8.72 Million
Q4 2021 Feb 14, 2022	SELL	$100.76 - $138.36 $2.02 Million - $2.77 Million	-20,000 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$132.37 - $176.78 $1.99 Million - $2.65 Million	-15,000 Reduced 42.86%	20,000 $2.68 Million
Q2 2021 Aug 16, 2021	BUY	$60.88 - $161.91 $2.13 Million - $5.67 Million	35,000 New	35,000 $5.67 Million

336

96.1M

1.06M

863K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $719M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Ghisallo Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ghisallo Capital Management LLC with notifications on news.